NovaBridge Biosciences (NBP) Profit After Tax (2019 - 2025)

NovaBridge Biosciences (NBP) has 5 years of Profit After Tax data on file, last reported at -$103.8 million in Q4 2025.

• Quarterly Profit After Tax fell 1057.41% year-over-year to -$103.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$88.3 million (down 16198.89% YoY) and the FY2025 annual result came in at -$88.3 million, down 497.39% from the prior year.
• Profit After Tax declined to -$103.8 million in Q4 2025 per NBP's latest filing, from $24.1 million in the prior quarter.
• Across five years, Profit After Tax topped out at $25.4 million in Q2 2024 and bottomed at -$103.8 million in Q4 2025.
• The 3-year median for Profit After Tax is -$5.5 million (2025), against an average of -$13.2 million.
• Peak annual rise in Profit After Tax reached 217.79% in 2025, while the deepest fall reached 1057.41% in 2025.
• Tracing NBP's Profit After Tax over 3 years: stood at -$36.9 million in 2023, then jumped by 129.38% to $10.8 million in 2024, then sank by 1057.41% to -$103.8 million in 2025.
• Per Business Quant, the three latest NBP Profit After Tax figures stand at -$103.8 million (Q4 2025), $24.1 million (Q3 2025), and -$5.5 million (Q2 2025).

Peer Comparison